Drug Profile
Raxofelast
Alternative Names: IRFI 016Latest Information Update: 04 May 2007
Price :
$50
*
At a glance
- Originator Biomedica Foscama
- Class Benzofurans; Benzopyrans; Expectorants
- Mechanism of Action Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis; Diabetic complications
Most Recent Events
- 25 Oct 2005 This compound is still in active development
- 27 Jun 2001 Phase-II clinical trials for Atherosclerosis in Italy (PO)
- 27 Jun 2001 Phase-II clinical trials for Atherosclerosis in United Kingdom (PO)